排序方式: 共有40条查询结果,搜索用时 46 毫秒
31.
Imanol Montoya Santiago Esnaola Montserrat Calvo Elena Aldasoro Covadonga Audicana Marc Marí-Dell’Olmo 《Gaceta sanitaria / S.E.S.P.A.S》2019,33(3):289-292
Health surveys are a key tool for decision-making in health policies and health services planning. The use of small-area statistical methods that use information at different geographic levels may be useful for estimating health indicators at a lower geographical level than originally considered in the survey design. 相似文献
32.
Antonio Viúdez Guillermo Crespo María Luisa Gómez Dorronsoro Imanol Arozarena Juan Jesús Marín-Méndez Ana Custodio Marta Benavent Saioa Goñi Beatriz García-Paredes Jorge Hernando Maika Durantez Vicente Alonso María del Carmen Riesco Carlos López Paula Jiménez-Fonseca Borja López San Vicente Iranzu González-Borja Isabel Sevilla Ana De Jesús Acosta 《Pancreatology》2021,21(1):215-223
BackgroundPancreatic neuroendocrine tumors are rare neoplasms for which few predictive and/or prognostic biomarkers have been validated. Our previous work suggested the potential of the combined expression of N-myc downstream-regulated gen-1 (NDRG-1), O6-methylguanine DNA methyltransferase (MGMT) and Pleckstrin homology-like domain family A member 3 (PHLDA-3) as prognostic factors for relapse and survival.MethodsIn this new multicenter study we evaluated immunohistochemistry expression in 76 patients with advanced PanNET who were treated with capecitabine-temozolomide or everolimus. Based on the immunohistochemistry panel, an immunohistochemistry prognostic score (IPS) was developed.ResultsIn patients treated with capecitabine and temozolomide, low IPS was an independent prognostic factor for progression-free-survival and overall-survival. Similar findings were observed with highest IPS for overall-survival in patients treated with everolimus.ConclusionFrom our knowledge, it is the first time that a simple IPS could be useful to predict outcome for patients with metastatic pancreatic neuroendocrine tumors treated with everolimus or capecitabine and temozolomide. 相似文献
33.
34.
Treatment of Small Vessel Disease With the Paclitaxel Drug‐Eluting Balloon: 6‐Month Angiographic and 1‐Year Clinical Outcomes of the Spanish Multicenter Registry
下载免费PDF全文
![点击此处可从《Journal of interventional cardiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Beatriz Vaquerizo M.D. Ph.D. Faustino Miranda‐Guardiola M.D. Eduardo Fernández M.D. José Ramón Rumoroso M.D. Josep Antoni Gómez‐Hospital M.D. Francisco Bossa M.D. Andrés Iñiguez M.D. Imanol Oategui M.D. Antonio Serra M.D. 《Journal of interventional cardiology》2015,28(5):430-438
Background
Small vessel disease (SMD) remains a major challenge because of the increased risk of restenosis. We sought to assess the efficacy and safety of a paclitaxel‐eluting balloon (PEB) in patients with SMD.Methods and Results
One‐hundred and four patients with native coronary lesions in small vessels treated by using a PEB were included in this prospective multicenter registry. In each case, after regular balloon dilatation, a larger PEB was inflated for a minimum of 45–60 seconds. Patients were 65 ± 10 years old, 43% diabetic, and 58% presented acutely. Angiographic success was 93% (7% bailout BMS implantation due to coronary dissection). The rate of major adverse cardiac events (MACE) at 12 months was 4.8% (1.9% cardiac death, 1.0% MI, and 2.9% TLR). One definite stent thrombosis was reported at 6 months in a patient with bailout BMS implantation. At 7 months, late loss was 0.31 ± 0.2 mm. Bail‐out BMS after DEB use, was an independent predictor of MACE, HR 18.74, 95%CI (2.58–135.84) and TLR, HR 30.99, 95%CI (2.79–344.07).Conclusion
The use of this PEB for the treatment of SMD provides excellent 1‐year outcomes with only 4.8% MACE. The need for a bailout BMS was a strong predictor of MACE and TLR. (J Interven Cardiol 2015;28:430–438)35.
36.
Rosa Puigpinós-Riera Marc Marí-Dell’Olmo Mercè Gotsens Carme Borrell Gemma Serral Carlos Ascaso Montse Calvo Antonio Daponte Felicitas M Domínguez-Berjón Santiago Esnaola Ana Gandarillas Gonzalo López-Abente Carmen M Martos Miguel A Martínez-Beneito Agustín Montes-Martínez Imanol Montoya Andreu Nolasco Isabel M Pasarín Maica Rodríguez-Sanz Marc Sáez Pablo Sánchez-Villegas 《International journal of health geographics》2011,10(1):1-2
37.
38.
Arozarena I Sanchez-Laorden B Packer L Hidalgo-Carcedo C Hayward R Viros A Sahai E Marais R 《Cancer cell》2011,19(1):45-57
- Download : Download high-res image (128KB)
- Download : Download full-size image
39.
Ruiz-Cabello J Regadera J Santisteban C Graña M Pérez de Alejo R Echave I Avilés P Rodriguez I Santos I Gargallo D Cortijo M 《NMR in biomedicine》2002,15(3):204-214
We have studied an animal model of acute local inflammation in muscle induced by Aspergillus fumigatus by using magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS). We have compared our data to those found using histopathology and segmentation maps obtained by the mathematical processing of three-dimensional T2-weighted MRI data via a neural network. The MRI patterns agreed satisfactorily with the clinical and biological evidence of the phases of acute local infection and its evolution towards chronicity. The MRS results show a statistically significant increase in inorganic phosphate and a significant decrease in phosphocreatine levels in the inflamed region. Image segmentation made with a self-organizing, neural-network map yielded a set of ordered representatives that remained constant for all animals during the inflammatory process, allowing a non-invasive, three-dimensional identification and quantification of the inflamed infected regions by MRI. 相似文献
40.
Salas Arrambide M Gabaldón Poc O Mayoral Miravete JL Pérez-Yarza EG Amayra Caro I 《Anales de pediatría (Barcelona, Spain : 2003)》2005,62(5):450-457
Palliative care is essential in the pediatric intensive care unit (PICU). Because of the mortality rates and the presence of life-threatening conditions in children admitted to the PICU, pediatricians must be prepared to provide palliative care independently of cure-directed therapies. The present article reviews certain issues, including the decision-making process in the PICU, psychosocial needs and susceptibility to burnout among PICU staff, and the emotions and attitudes of the staff when a child dies. We provide some guidelines on how to act when a child dies, how to meet with parents after the child's death and how to follow-up parental bereavement. Strategies that can help PICU pediatricians to cope with the numerous loses they experience are suggested. 相似文献